Carregant...

Rationale and Design for the Intramyocardial Injection of Autologous Bone Marrow Mononuclear Cells for Patients with Chronic Ischemic Heart Disease and Left Ventricular Dysfunction Trial (FOCUS)

BACKGROUND: The increasing worldwide prevalence of coronary artery disease (CAD) continues to challenge the medical community. Management options include medical and revascularization therapy. Despite advances in these methods, CAD is a leading cause of recurrent ischemia and heart failure, posing s...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Willerson, James T., Perin, Emerson C., Ellis, Stephen G., Pepine, Carl J., Henry, Timothy D., Zhao, David X.M., Lai, Dejian, Penn, Marc S., Byrne, Barry J., Silva, G, Gee, Adrian, Traverse, Jay H., Hatzopoulos, Antonis K., Forder, John R., Martin, Daniel, Kronenberg, Marvin, Taylor, Doris A., Cogle, Christopher R., Baraniuk, Sarah, Westbrook, Lynette, Sayre, Shelly L., Vojvodic, Rachel W., Gordon, David J., Skarlatos, Sonia I., Moyé, Lemuel A., Simari, Robert D.
Format: Artigo
Idioma:Inglês
Publicat: 2010
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2921924/
https://ncbi.nlm.nih.gov/pubmed/20691824
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ahj.2010.03.029
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!